Jamjoom Pharmaceuticals Factory Company (SASE: 4015)
Health Care · Pharmaceuticals · SA
SR128.00
+0.95% today · -19.0% 1Y
Jamjoom Pharmaceuticals Factory Company (SASE: 4015) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.39B.
Over the last twelve months the share price has lost 19.0%, trading between 125.00 and 165.30.
Tweenvest scores Jamjoom Pharmaceuticals Factory Company across four factors: quality 93/100, value 81/100, dividend 69/100. Its strongest factor is quality.
4015 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.39B
- Revenue (TTM)
- $418.84M
- P/E
- 18.64
- EPS
- 6.87
- Dividend yield
- 3.44%
- Beta (5Y)
- 0.36
- 52-week high
- SR165.30
- 52-week low
- SR125.00
- Avg volume (3M)
- —
- Shares outstanding
- 70.00M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Curaleaf Holdings, Inc.TSX: CURA | $2.47B | CA$13.31 | -6.33% |
| Almirall, S.A.BME: ALM | $2.46B | €9.88 | -1.98% |
| Liquidia CorporationNasdaqCM: LQDA | $2.45B | $28.11 | +2.67% |
| Aether Industries LimitedNSEI: AETHER | $2.40B | Rs1,748.10 | +4.68% |
| Harmony Biosciences Holdings, Inc.NasdaqGM: HRMY | $2.35B | $38.62 | -4.12% |
| HUTCHMED (China) LimitedAIM: HCM | $2.33B | £2.03 | -2.87% |
| Tonghua Dongbao Pharmaceutical Co., Ltd.SHSE: 600867 | $2.30B | CN¥7.88 | +0.25% |
| Shandong Buchang Pharmaceuticals Co., Ltd.SHSE: 603858 | $2.29B | CN¥14.81 | +1.16% |
Figures last refreshed Oct 11, 2026.